• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

ABO and Lewis Blood Groups Linked to Lower COVID-19 Susceptibility

October 26, 2022

Blood group O has been associated with decreased risk of SARS-CoV-2 infection in several small studies.  In order to confirm these observations and determine if other blood groups are associated with SARS-CoV-2 infection, researchers in Denmark utilized data from the nationwide SCANDAT database.  SCANDAT is a complete database of all Danish blood donors, including data on SARS-CoV-2 PCR and antigen tests, sex, age, and more than a dozen blood groups.  Using data from SCANDAT from February 2020 to August 2021, 36,068 of 650,156 Danish blood donors tested positive for SARS-CoV-2.  In a multivariable analysis that included adjustment for age and sex, two antigens—blood type O and Lewis Lea—were associated with a lower odds of SARS-CoV-2 infection.  The odds of infection for blood types B, A, and AB compared to O were 1.10 (95% C.I., 1.06 to 1.14), 1.17 (95% C.I., 1.14 to 1.20), and 1.20 (95% C.I. 1.14 to 1.26), respectively.  The odds of infection for the non-secretor Lewis phenotype Lea was 0.88 (95% C.I., 0.78 to 0.99) compared to the secretor phenotype where the ABO blood group antigens are present in other body fluids including mucus.  No associations were found between blood groups and hospitalization or long-COVID.  Further research is needed to understand the mechanisms of blood groups and COVID-19 susceptibility.

Reference:

Moslemi C, Sækmose, Larsen R, Brodersen T, et al.  A large cohort study of the effects of the Lewis, ABO, 13 other blood groups and secretor status on COVID-19 susceptibility, severity, and long COVID-19.   Transfusion 2022

Filed Under

  • News
  • Serology/Genotyping

Recommended

  • New PLASMIC Scoring System to Help Diagnose Thrombotic Thrombocytopenic Purpura

  • Sex-Matched Transfusions May Reduce Mortality

  • Pathogen Reduction Technologies and Hemostatic Efficacy of Platelets

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • Directed Blood Donations Should be Limited

  • Babesia Infection Reduces Red Cell Deformability

  • New Erythropoietin Gene Variants Linked to Hereditary Erythrocytosis

  • Multifaceted Threats to the Blood Supply from Climate Change

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley